Skip to main navigation Skip to search Skip to main content

Case report of increased exposure to antiretrovirals following sleeve gastrectomy

  • Sarah Israel*
  • , Hila Elinav
  • , Ram Elazary
  • , Daniel Porat
  • , Roni Gibori
  • , Arik Dahan
  • , Carmil Azran
  • , Ehud Horwitz
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Bariatric surgery is increasingly performed in morbidly obese HIV patients. Limited data exist regarding antiretroviral drug exposure after bariatric surgery. We report a case of a morbidly obese HIV patient who underwent sleeve gastrectomy. Abacavir, lamivudine, and dolutegravir therapeutic drug monitoring was performed at several time points pre- and postsurgery. Significantly increased levels were measured, particularly for abacavir, whose levels increased ~12-fold. Several mechanistic explanations for these findings are discussed.

Original languageEnglish
Article numbere02453-19
JournalAntimicrobial Agents and Chemotherapy
Volume64
Issue number4
DOIs
StatePublished - 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2020 American Society for Microbiology. All Rights Reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antiretrovirals
  • Bariatric surgery
  • Obesity
  • Sleeve gastrectomy

Fingerprint

Dive into the research topics of 'Case report of increased exposure to antiretrovirals following sleeve gastrectomy'. Together they form a unique fingerprint.

Cite this